EHA Library - The official digital education library of European Hematology Association (EHA)

SPECIFICATION OF HEMATOPOIETIC STEM CELL FATE VIA MODULATION OF MITOCHONDRIAL ACTIVITY
Author(s): ,
Mukul Girotra
Affiliations:
Ludwig Institute for Cancer Research,University of Lausanne,Epalinges,Switzerland
,
Marcela Rincon-Restrepo
Affiliations:
Ludwig Institute for Cancer Research,University of Lausanne,Epalinges,Switzerland
,
Caroline Monnard
Affiliations:
Nestlé Institute of Health Sciences SA,Lausanne,Switzerland
,
George Coukos
Affiliations:
Ludwig Institute for Cancer Research,University of Lausanne,Epalinges,Switzerland
,
Serge Rezzi
Affiliations:
Nestlé Institute of Health Sciences SA,Lausanne,Switzerland
Nicola Vannini
Affiliations:
Ludwig Institute for Cancer Research,University of Lausanne,Epalinges,Switzerland
(Abstract release date: 05/17/18) EHA Library. Girotra M. 06/17/18; 214627; S1590
Mukul Girotra
Mukul Girotra
Contributions
Abstract

Abstract: S1590

Type: Oral Presentation

Presentation during EHA23: On Sunday, June 17, 2018 from 08:00 - 08:15

Location: Room A10

Background

A tight control of hematopoietic stem cell (HSC) fate is crucial for lifelong blood production. Therefore, a fine balance of quiescence, self-renewal, and differentiation is key to maintain the HSC pool and blood homeostasis. In recent years cellular metabolism has emerged as a crucial regulator of HSC fate. HSCs differ from their committed progeny by relying primarily on anaerobic glycolysis rather than mitochondrial oxidative phosphorylation for energy production. However, whether this change in the metabolic program is the cause or a consequence of the unique function of HSCs remains unknown.

Aims
Here we asked if mitochondrial activity can be used as a reliable readout for functional HSCs and if modulation of mitochondrial activity results in enhancement of HSC function.

Methods
We used in vivo long term blood reconstitution assays as a readout of HSC functionality.

Results

We previously demonstrated that modulation of mitochondrial metabolism affects HSC fate, by chemically uncoupling the electron transport chain we were able to maintain HSC function in culture conditions that normally induce rapid differentiation (Vannini N, Girotra M. et al., Nat Comm 2016). Moreover, we demonstrated that modulation of mitochondrial activity in ex-vivo cultured human HSCs, via NAD+ boosting agent Nicotinamide Riboside (NR), results in better long-term blood production in serially transplanted humanized mice (Under Revision). Here we proceeded to carry out a mini screen, using mitochondrial activity as readout, to identify novel metabolic modulators that can be used to enhance HSC activity and function.

Conclusion

Our data thus reveal a causal relationship between mitochondrial metabolism and fate choice of HSCs, and also provide a valuable tool to identify optimal ex vivo conditions for HSC expansion and improve the outcome for patients suffering from bone marrow insufficiency.

Session topic: 24. Hematopoiesis, stem cells and microenvironment

Keyword(s): Hematopoietic Stem Cell, Human CD34+ cell, Mitochondria, Stem cell marker

Abstract: S1590

Type: Oral Presentation

Presentation during EHA23: On Sunday, June 17, 2018 from 08:00 - 08:15

Location: Room A10

Background

A tight control of hematopoietic stem cell (HSC) fate is crucial for lifelong blood production. Therefore, a fine balance of quiescence, self-renewal, and differentiation is key to maintain the HSC pool and blood homeostasis. In recent years cellular metabolism has emerged as a crucial regulator of HSC fate. HSCs differ from their committed progeny by relying primarily on anaerobic glycolysis rather than mitochondrial oxidative phosphorylation for energy production. However, whether this change in the metabolic program is the cause or a consequence of the unique function of HSCs remains unknown.

Aims
Here we asked if mitochondrial activity can be used as a reliable readout for functional HSCs and if modulation of mitochondrial activity results in enhancement of HSC function.

Methods
We used in vivo long term blood reconstitution assays as a readout of HSC functionality.

Results

We previously demonstrated that modulation of mitochondrial metabolism affects HSC fate, by chemically uncoupling the electron transport chain we were able to maintain HSC function in culture conditions that normally induce rapid differentiation (Vannini N, Girotra M. et al., Nat Comm 2016). Moreover, we demonstrated that modulation of mitochondrial activity in ex-vivo cultured human HSCs, via NAD+ boosting agent Nicotinamide Riboside (NR), results in better long-term blood production in serially transplanted humanized mice (Under Revision). Here we proceeded to carry out a mini screen, using mitochondrial activity as readout, to identify novel metabolic modulators that can be used to enhance HSC activity and function.

Conclusion

Our data thus reveal a causal relationship between mitochondrial metabolism and fate choice of HSCs, and also provide a valuable tool to identify optimal ex vivo conditions for HSC expansion and improve the outcome for patients suffering from bone marrow insufficiency.

Session topic: 24. Hematopoiesis, stem cells and microenvironment

Keyword(s): Hematopoietic Stem Cell, Human CD34+ cell, Mitochondria, Stem cell marker

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies